George Church
Professor, Harvard Medical School and MIT
2026 event and registration
Longevity 121 · Boston 2026: AI-Driven Healthy Longevity
Date
October 4, 2026
Venue
Harvard University
Tentative venue
MIT Stata Center, Cambridge, MA, USA
2026
Upcoming USA edition
8
Tentative speakers
5
Core forum themes
Distinguished Speakers (Tentative)
The speaker group spans aging mechanisms, epigenetic clocks, neural aging, regenerative medicine, synthetic biology, and the translation of healthy longevity research.
Vadim Gladyshev
Member of the U.S. National Academy of Sciences and National Academy of Engineering; Professor, Harvard Medical School and MIT
Robert Langer
Member of the U.S. National Academies of Sciences, Engineering, and Medicine and the American Academy of Arts and Sciences; Professor, MIT
More distinguished speakers will be announced soon.
Forum Overview
According to data from the United Nations and the World Health Organization, the world is entering an unprecedented era of population aging. By 2030, one in six people worldwide will be aged 60 or older; by 2050, this population is projected to reach 2.1 billion.
This profound demographic shift is reshaping societies, healthcare systems, and economies. It also raises one of the defining questions in contemporary life science and medicine: Can we better understand, measure, and intervene in the aging process, thereby extending human healthspan?
Forum Themes
The program spans diagnostics, discovery, intervention, translation, and commercialization for healthspan extension.
Aging Diagnostics & Biomarkers
Focused on biological age assessment, epigenetic clocks, blood biomarkers, multi-omics testing, and their applications in clinical practice and health management.
AI & Longevity Drug Discovery
Exploring how artificial intelligence can accelerate target identification, candidate screening, mechanism prediction, and the development of anti-aging interventions.
Aging Intervention & Regenerative Medicine
Covering cell therapy, tissue repair, regenerative medicine, metabolic interventions, and innovative therapeutic approaches for age-related diseases.
Clinical Translation of Healthy Longevity
Discussing key challenges and solutions in moving from laboratory discoveries to clinical validation and from scientific breakthroughs to real-world applications.
Longevity Industry & Commercialization
Connecting pharmaceutical companies, biotech firms, medical institutions, aesthetic medicine providers, supplement brands, investors, and entrepreneurs to explore future opportunities in the longevity industry.
Who Should Attend
Longevity 121 is a long-term meeting platform for healthy longevity technology, connecting aging science, clinical translation, artificial intelligence, industry innovation, and the investment ecosystem.
Researchers
Physicians and clinical experts
Pharmaceutical and biotech companies
AI companies
Investment institutions
Healthcare institutions
Aesthetic medicine providers
Supplement brands
Longevity industry professionals
Partnership Inquiries
For sponsorship, partnership, speaking opportunities, or closed-door session inquiries, please contact the conference team.
Chenxi Li
Gavin Zhou